Skip to main content
Arctic Bioscience logo

Arctic Bioscience — Investor Relations & Filings

Ticker · ABS ISIN · NO0010859580 LEI · 549300Z2HW6I989Q2C78 OL Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2022-06-01 Director's Dealing
Country NO Norway
Listing OL ABS

About Arctic Bioscience

https://arctic-bioscience.com/

Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical and nutraceutical products derived from marine membrane lipids. The company utilizes proprietary technology to extract bioactive compounds from herring roe, sourced from sustainable, MSC-certified fisheries. Its nutraceutical product line, marketed under the brand name Romega, consists of high-DHA Omega-3 phospholipid extracts. The pharmaceutical division is focused on developing a novel drug candidate for the treatment of mild-to-moderate psoriasis, aligning with its mission to create therapies for autoimmune disorders. The company's work is supported by extensive research and development to validate the efficacy of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Arctic Bioscience - Mandatory notification of trade' and explicitly states that a Medical Director bought shares. It references disclosure requirements under Regulation EU 596/2014 (MAR) article 19, which pertains to insider transactions. This directly matches the definition for Director's Dealing (DIRS). Although it mentions an 'attached notification,' the core content is the insider trade disclosure itself, making DIRS more specific than RPA or RNS. The document length is short (1596 chars), but the primary purpose is reporting the trade, not just announcing a separate report.
2022-06-01 English
Arctic Bioscience - Presentation at ABG Sundal Collier Life Science Summit
Investor Presentation Classification · 98% confidence The document text explicitly states it is a 'Presentation at ABG Sundal Collier Life Science Summit' and details the CEO and Medical Director presenting. This content aligns perfectly with an Investor Presentation (IP), which typically includes company strategy, pipeline updates (like HRO350 for psoriasis), and market focus, delivered at an industry conference.
2022-05-18 English
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information Classification · 100% confidence The document title is "PROTOKOLL FRA ORDINÆR GENERALFORSAMLING I ARCTIC BIOSCIENCE AS" (MINUTES FROM ORDINARY GENERAL MEETING IN ARCTIC BIOSCIENCE AS). The text details the proceedings, resolutions passed (including approval of annual accounts, board remuneration, and capital increase authorization), and the results of shareholder voting that took place on May 5, 2022. This content perfectly matches the definition of minutes or records from an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2022-05-05 Norwegian
Arctic Bioscience - Minutes of the Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states it contains the "Minutes of the Annual General Meeting" of Arctic Bioscience AS, held on May 5, 2022. The content confirms that agenda items were addressed and approved, and it mentions that the minutes are attached. This directly corresponds to the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting.
2022-05-05 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text is a structured notification template detailing a transaction involving a person discharging managerial responsibilities (a board member's related entity, Vartdal Holding AS) in the issuer (ARCTIC BIOSCIENCE AS). Specifically, it reports an 'Aksjekjøp' (Share Purchase) by an insider's associated entity. This perfectly matches the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives (insider trades). The corresponding code is DIRS.
2022-04-22 English
Arctic Bioscience - Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document explicitly states it is a "Mandatory notification of trade" concerning a purchase of shares by Vartdal Holding AS, which is closely associated with a member of the Board of Directors (Jan Endre Vartdal). This transaction falls under insider trading disclosure requirements, specifically referencing Regulation EU 596/2014 (MAR) article 19. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). The document length is short (2285 chars) and it mentions an 'attached notification', but the core content *is* the notification of the trade itself, making DIRS a more specific and accurate classification than a general RPA or RNS.
2022-04-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.